|
|
|
|
 |
|
SENSEX
|
 |
-445.59
|
-0.62%
|
|
71580.56
|
|
|
|
NIFTY
|
 |
-133.60
|
-0.62%
|
|
21577.20
|
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
|
14524.07
|
|
|
|
Nikkei 225
|
 |
89.13
|
0.27%
|
|
33377.42
|
|
|
|
FTSE 100
|
 |
-33.50
|
-0.43%
|
|
7689.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04-01-2024
|
|
|
|
| Shalby Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31, 2023 |
|
|
|
|
|
03-01-2024
|
|
|
|
| Shalby Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31, 2023 |
|
|
|
|
|
27-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
27-12-2023
|
|
|
|
| SHALBY LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
26-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
26-12-2023
|
|
|
|
| SHALBY LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
19-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding 'Company's Wholly-Owned Subsidiary Mars Medical Devices Ltd Approved To Invest 200,000 Pref. Shares Of Its Subsidiary Shalby Global Technologies Pte. Ltd. on 18-12-2023'. |
|
|
|
|
|
18-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding 'Company's Wholly-Owned Subsidiary Mars Medical Devices Ltd Approved To Invest 200,000 Pref. Shares Of Its Subsidiary Shalby Global Technologies Pte. Ltd. on 18-12-2023'. |
|
|
|
|
|
13-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding 'Intimation for availing of Working Capital Facilities'. |
|
|
|
|
|
12-12-2023
|
|
|
|
| Shalby Limited has informed the Exchange regarding 'Intimation for availing of Working Capital Facilities'. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|